Celltrion, Inc.

₩211,000As of Sun 8 Nov 2026, 12:00 UTC
KRX:068270Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 11.11%
Div yield 0.34%
ROE 9.11%
Biotechnology
Beta (5Y) 0.24
PE TTM 30.85
TSR TTM 26.70%
Mkt cap ₩48.20T
ROIC 6.65%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩226,805
7.49%
(32.32%)
Hold 2|10|1|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
2,048
2,186
2,078
2,128
(1.97%)
8.03%
6.51%
2.20%
Revenue₩B
5,400
5,292
5,534
5,803
10.95%
6.01%
12.66%
13.13%
Peers (US$35.54B)
Cap (US$)
PE
10.29B
76.81x
33.28B
45.84x
Capital
TTM
5Y
10Y
Leveragex
0.561
0.099
0.085
EBIT/Intx
1.174
0.289
0.289
Own earn%
76.81
16.51
(13.12)
Sh yield%
29.50
28.68
30.08
Owners
Insiders/Inst%
0.61
60.60
Short interest%
2.03
SBC / revenue%
0.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
9–16
$1 testx
1.0
Incr. ROIC%
61